REYATAZ (ATAZANAVIR)

**Product type:** Human Prescription Drug

**Active ingredient:** ATAZANAVIR SULFATE

**Strength:** 300 mg/1

**Dosage form:** Capsule, Gelatin Coated

**Route:** Oral

**Labeler:** E.R. Squibb & Sons, L.L.C.

**Marketing category:** NDA (NDA021567)

**Pharmacologic class:** Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]